SILVAGNI, ETTORE
 Distribuzione geografica
Continente #
NA - Nord America 806
AS - Asia 154
EU - Europa 152
SA - Sud America 24
AF - Africa 4
OC - Oceania 4
Totale 1.144
Nazione #
US - Stati Uniti d'America 798
CN - Cina 71
IT - Italia 63
DE - Germania 28
TR - Turchia 23
GB - Regno Unito 21
ID - Indonesia 18
UA - Ucraina 17
FR - Francia 12
IN - India 7
MX - Messico 7
BO - Bolivia 6
PE - Perù 6
BR - Brasile 5
HK - Hong Kong 5
IQ - Iraq 5
PH - Filippine 5
SA - Arabia Saudita 5
AU - Australia 4
VN - Vietnam 4
CH - Svizzera 3
EC - Ecuador 3
JP - Giappone 3
AR - Argentina 2
BE - Belgio 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
FI - Finlandia 2
IL - Israele 2
NG - Nigeria 2
OM - Oman 2
PK - Pakistan 2
SE - Svezia 2
TW - Taiwan 2
CA - Canada 1
Totale 1.144
Città #
Fairfield 108
Chandler 102
Woodbridge 65
Ashburn 55
Houston 43
Seattle 39
Wilmington 39
Cambridge 35
Ann Arbor 32
Princeton 28
Shanghai 20
Beijing 18
Ferrara 18
Izmir 18
Jacksonville 16
Nanjing 14
San Diego 11
Padova 9
Los Angeles 8
Addison 7
Bologna 7
Jakarta 6
Lima 6
Baghdad 5
Chicago 5
Vicenza 5
Cagliari 4
Ferrara di Monte Baldo 4
Hong Kong 4
Hounslow 4
La Paz 4
London 4
Makkah 4
Mountain View 4
New York 4
Norwalk 4
Redwood City 4
Shenyang 4
Boardman 3
Bremen 3
Changsha 3
Mérida 3
New Delhi 3
Palembang 3
Tokyo 3
Uster 3
Alexandria 2
Americana 2
Atlanta 2
Bhilai 2
Bogor 2
Brussels 2
Cabanatuan City 2
Cologne 2
Cuenca 2
Davao City 2
Dearborn 2
Dong Ket 2
Gustavo Adolfo Madero 2
Guwahati 2
Ho Chi Minh City 2
Islamabad 2
Jiaxing 2
Manado 2
Melbourne 2
Milan 2
Muscat 2
Nanchang 2
Neiva 2
New Port Richey 2
New Taipei 2
Oceanside 2
Orange 2
Padang 2
Reston 2
Richmond 2
Salvador 2
San Rafael 2
Santa Cruz 2
South San Francisco 2
Statesboro 2
Sydney 2
Absecon 1
Allen 1
Bandung 1
Blacksburg 1
Castelnuovo Berardenga 1
Changchun 1
Charlotte 1
Chiswick 1
Esslingen am Neckar 1
Falls Church 1
Florence 1
Fremont 1
Guangzhou 1
Hamburg 1
Hanover 1
Hebei 1
Iloilo City 1
Jeddah 1
Totale 881
Nome #
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 167
Systemic lupus erythematosus: one year in review 2023 115
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 102
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 91
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 84
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 67
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 61
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 42
Biological and synthetic target DMARDs in psoriatic arthritis 41
One year in review 2018: novelties in the treatment of rheumatoid arthritis 38
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 34
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 33
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 29
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 28
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 28
One year in review 2019: novelties in the treatment of rheumatoid arthritis 26
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 24
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 24
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 23
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 20
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 18
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 17
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 14
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 14
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 11
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 11
Novel insights into the management of rheumatoid arthritis: one year in review 2022 11
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 10
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 10
One year in review 2021: novelties in the treatment of rheumatoid arthritis 10
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 10
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 8
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 7
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 7
One year in review 2020: novelties in the treatment of rheumatoid arthritis 6
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study. 4
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 4
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 4
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 4
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 4
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 4
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 3
Novel insights into the management of rheumatoid arthritis: one year in review 2023 3
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 3
Systemic lupus erythematosus: one year in review 2024 1
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 1
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 1
Totale 1.277
Categoria #
all - tutte 9.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201984 0 0 0 0 0 0 0 0 0 19 25 40
2019/2020172 31 7 4 25 15 14 22 11 17 13 8 5
2020/2021162 4 7 4 17 29 11 11 17 13 23 17 9
2021/2022247 12 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024308 21 23 13 8 56 6 9 18 25 129 0 0
Totale 1.277